The Role of CARD9 Deficiency in Neutrophils

Sheng, Ruanmei; Zhong, Xiaoming; Yang, Zhiwen; Wang, Xuemin

doi:https://doi.org/10.1155/2021/6643603

Mediators of Inflammation

On this page

Abstract Introduction Conclusions Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 6643603 | https://doi.org/10.1155/2021/6643603

The Role of CARD9 Deficiency in Neutrophils

Ruanmei Sheng,^1,2Xiaoming Zhong,³Zhiwen Yang,^1,2and Xuemin Wang^1,2

Academic Editor: Joilson O. Martins

Received16 Oct 2020

Revised02 Dec 2020

Accepted24 Dec 2020

Published05 Jan 2021

Abstract

Neutrophils play a critical role in innate immune defense and directly contribute to infectious and autoimmune ailments. Great efforts are underway to better understand the nature of neutrophilic inflammation. Of note, CARD9, a myeloid cell-specific signaling protein that mainly expresses in macrophages and dendritic cells, is also present in neutrophils, emerging as a critical mediator for intercellular communication. CARD9–deficiency neutrophils display an increased susceptibility to fungal infection that primarily localize to the central nervous system, subcutaneous, and skin tissue. Additionally, CARD9–deficiency neutrophils are associated with some autoimmune diseases and even provide protection against a few bacteria. Here, the review summarizes recent preclinical and clinical advances that have provided a novel insight into the pathogenesis of CARD9 deficiency in neutrophils.

1. Introduction

CARD9 is a central integrator of innate and adaptive immunity that is mainly expressed in myeloid cells, especially in macrophages and dendritic cells. CARD9 as an intracellular adaptor molecule could activate NF–κB and/or MAPK signal pathways in macrophages and dendritic cells, leading to an inflammatory cascade against the invasive bacteria, fungi, and virus [1, 2].

Neutrophils are known as the most abundant circulating leukocytes, participating in the organization of the antimicrobial host defense, autoimmune, and aseptic inflammatory processes. Emerging evidence demonstrates that CARD9 is not only present in dendritic cells and macrophages but also in neutrophils, exhibiting a similar role in fungal infection, bacterial infection, and autoimmune diseases [3–5]. Different from the previously published paper on CARD9 deficiency in macrophages, myeloid, and dendritic cells, CARD9–deficiency neutrophils may greatly impair neutrophil functions, leading to fungal brain infection, arthritis, and dermatitis [3–5]. What is more, a novel mechanism that negative feedback regulation of Dok3-PP1 complex was found in neutrophils [6]. Thus, this review is to discuss the most recent findings on the pathogenesis of CARD9 in neutrophils, while the function of CARD9 in macrophages and dendritic cells is omitted here.

2. CARD9-Deficient Neutrophils and Fungal Infection

2.1. Fungal Brain Infection

Some findings have demonstrated that CARD9 deficiency gives rise to susceptibility to invasive fungal infection in the brain. In the central nervous system (CNS) of CARD9-deficient patients, significant eosinophil infiltration and defective neutrophil accumulation were observed [3, 4, 7–9]. Neutrophils act as critical mediators of host defenses against systemic C. albicans infection, whereas eosinophils do not play this role [10]. The phenomenon of CNS-specific neutropenia may be attributed to the deficiency of neutrophil-targeted chemoattractants. In the infected cerebrospinal fluid (CSF) of CARD9-deficient patients, a striking lack of neutrophil-targeted chemokines, namely, CXCL1, CXCL2, CXCL5, and IL-8, was detected [4, 11]. Conversely, the CSF of CARD9^+/+ patients with C. albicans meningitis exhibited significant induction of CXC neutrophil-recruiting chemokines [4, 11]. Furthermore, microglial deletion of CARD9 in the brain greatly reduced the neutrophil-recruitment of IL-1β and CXCL1 [11]. These data suggested that CARD9 plays an important role in the production of neutrophil-specific chemoattractant factors, promoting the accumulation of neutrophils at the infection site. Therefore, CARD9 deficiency might predispose patients to CNS infection as a result of CNS-specific neutropenia.

A total of three patients with CARD9 deficiency who suffer from Candida albicans meningitis have been reported, showing an intrinsic functional impairment in neutrophils [3–5]. CARD9-deficient neutrophils harvested from the three patients displayed a selective defect in fungal clearance.

A 13-year-old Asian girl was diagnosed with Candida dubliniensis meningoencephalitis [3]. As a result of c.214G>A and c.1118G>C mutations in the CARD9 gene, the patient showed a complete absence of CARD9 protein in neutrophils. CARD9-deficient neutrophils isolated from the patient’s peripheral blood displayed a specific killing defect for unopsonized C. albicans yeasts, but not opsonized C. albicans yeasts. Surprisingly, the ex vivo impaired killing capacity of CARD9-deficient neutrophils against unopsonized Candida yeasts could be effectively restored upon opsonization with human serum, potentially explaining the susceptibility of patients to Candida infection in the CNS [3]. Because of the blood-brain barrier, CNS parenchyma has limited access to plasma opsonization [12].

An 11-year-old girl, from North Carolina, USA, was reported with C. albicans infection of the CNS [4]. In this case, a c.170G>A CARD9 missense mutation induced the generation of full-length CARD9 protein, with similar CARD9 protein expression levels observed between the patient and healthy donor neutrophils; however, this mutation resulted in the impaired production of proinflammatory factors. Next, the study investigated the antifungal ability of CARD9-deficient neutrophils, indicating a selective killing defect against C. albicans yeasts rather than hyphae. In addition, CARD9-deficient neutrophils exhibited normal intrinsic cellular functions, including their transmigration from the blood into the infected brain and cellular survival in vivo.

A 4-year-old Turkish girl was hospitalized for chronic C. albicans meningitis [5]. The patient was reported to possess a homozygous point mutation in exon 6 (c.883C>T) of CARD9, which led to a lack of CARD9 protein in the patient’s neutrophils. The killing capacity of CARD9-deficient neutrophils was obviously impaired against nonopsonized C albicans yeasts, but functioned normally against serum-opsonized yeasts. The defective neutrophil function observed in the absence of serum opsonin might predispose patients to chronic C. albicans infection of the CNS where opsonization is naturally low.

2.2. Fungal Subcutaneous Infection

CARD9 deficiency in patients has been linked to subcutaneous phaeohyphomycosis caused by Phialophora verrucosa [13, 14]. The collected four patients presented with persistent red plaques and nodules on their cheeks and faces, showing a slight improvement and/or limited effect upon receiving antifungal drug therapy. In these patients, CARD9 deficiency exhibited a striking decrease of IL-17 and IL-22 in serum, impaired the differentiation of TH17 innate immune cells, and subsequently led to the patients’ suppressed antifungal immunity. Neutrophils isolated from CARD9-deficient patients showed marked downregulation of IL-8, TNF-α, and IL-6 inflammatory factors upon P. verrucosa stimulation. In addition, CARD9^˗/˗ neutrophils exhibited a selective defect in the killing of unopsonized P. verrucosa conidia, but their ability to kill P. verrucosa hyphae remained intact. The impaired fungal killing capacity in CARD9^-/- neutrophils could be completely restored in the presence of human serum. In view of the low level of serum opsonization in the subcutaneous tissue, CARD9 in human neutrophils was indispensable for the immune response to subcutaneous P. verrucosa infection.

2.3. Fungal Extrapulmonary and Pulmonary Infections

CARD9 deficiency in patients constituted an increasing susceptibility to extrapulmonary and pulmonary fungal infections [15–17]. For these patients, CARD9^-/- neutrophils exhibited normal intrinsic chemotaxis from the blood into the Aspergillus-infected tissue, and intact killing capacity, phagocytosis, and the induction of an oxidative burst upon fungus-specific stimulation [16, 17]. Interestingly, CARD9-deficient neutrophils showed an impaired killing capacity against Aspergillus fumigatus, including opsonized or unopsonized conidia and hyphae [17]. This differed from the previously reported selective defect in eliminating unopsonized C. albicans yeasts. Therefore, CARD9 in human neutrophils is indispensable for intraabdominal and pulmonary Aspergillus infections.

2.4. Molecular Mechanisms of CARD9-Deficient Neutrophils in Fungal Infections

In general, CARD9-deficiency patients greatly impaired the neutrophil functions, showed an inhibited secretion of inflammatory factor, and further resulted in the patients’ suppressed antifungal immunity, and eventually induced fungal infection in the CNS. In this study, Drewniak et al. uncovered the underlying mechanisms for eliminating nonopsonized C. albicans from patient’s neutrophils [3]. First, CARD9-deficient neutrophils displayed appropriate intrinsic functions, with a completely normal capacity to generate reactive oxygen species, NADPH oxidase activity, adhesion, chemotaxis, degranulation of azurophilic and specific granules, and only a slight decrease in IL-8 release in response to various pathogens. Second, the phagolysosomes of CARD9-deficient neutrophils were found to contain more Candida yeasts than the control neutrophils, showing a significantly enlarged appearance. Neutrophil production in the phagolysosomes was induced by the increased osmotic pressure resulting from the breakdown of microbial proteins after intracellular killing [18]. Recently, Gazendam et al. discovered that human neutrophils kill invading C. albicans through two independent and distinct mechanisms [19]. The first mechanism for unopsonized C. albicans clearance was dependent on complement receptor 3 (CR3) recognitions and then triggering the downstream signaling including spleen-tyrosine kinase (Syk), phosphatidylinositol-3-kinase (PI3K), and CARD9, but independent of NADPH oxidase activation. The second mechanism for serum-opsonized C. albicans clearance depended on Fcγ receptors, protein kinase C, and reactive oxygen species production by the NADPH oxidase system, but was independent of CARD9 signaling. Briefly, the presence of two independent pathways for fungal killing depended on the recognition of either unopsonized or opsonized C. albicans by human serum or IgG (Figure 1). Due to the low level of IgG opsonization in the fungal-infected CSF [20], the CARD9-dependent CR3-Syk-PI3K pathway played a critical role in eliminating nonopsonized C. albicans, leading to susceptibility to CNS fungal disease in the absence of CARD9 in neutrophils. These findings provided further insight into the intrinsic functional defects in neutrophils in CNS-specific fungal infections.

CARD9-mediated signaling drives an inflammatory circuit that triggers an excessive inflammatory response [21]. After CARD9 phosphorylation at Thr231 by PKCδ, CARD9 protein interacts directly with Bcl-10 to form the signaling complex. The CARD9/Bcl-10 complex induces the activation of NF-κB and MAPKs and the subsequent release of inflammatory cytokines (Figure 2).

This study provided novel mechanistic insight into CARD9-induced inflammatory signaling [6]. In neutrophils, the downstream of kinase 3 (Dok3) was found to interact with protein phosphatase 1 (PP1), bringing PP1 into the vicinity of CARD9, which maintained CARD9 protein dephosphorylation in an inactive state. Upon dissociation of the Dok3-PP1 complex from CARD9, CARD9 was phosphorylated by PKCδ, and NF-κB was subsequently activated [6]. Thereby, Dok3 and PP1 were regarded as critical regulators of CARD9 dephosphorylation, negatively regulating CARD9 activity in neutrophils (Figure 2).

3. CARD9-Deficient Neutrophils and Bacterial Infection

Moraxella catarrhalis, a Gram-negative bacterium, is a common cause of chronic obstructive pulmonary disease (COPD). Neutrophil numbers in the patient’s respiratory tract are found to increase significantly, triggering antimicrobial activity.

The membrane surface of human neutrophils displays a distinct carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) that can specifically bind to ubiquitous surface protein A1 (UspA1) of M. catarrhalis. After UspA1-CEACAM3 interactions, the CARD9 adaptor molecule was activated, leading to a significant increase in the production of reactive oxygen species, granulocyte degranulation, NF-κB, and IL-8 in neutrophils. Conversely, CARD9 deficiency in neutrophils resulted in significant inhibition of the NF-κB inflammatory signaling pathway upon stimulation with M. catarrhalis [22].

Because of their short cellular lifespan, it is not currently possible to investigate the molecular mechanisms of action of human neutrophils using in vitro RNA interference. Instead, an acute promyelocytic leukemia-derived cell line NB4 was used as an in vitro cellular model in this study. To provide evidence for the CARD9-mediated CEACAM3-NF-κB pathway, CARD9^-/- neutrophils from patients infected with M. catarrhalis need to be further investigated in the future [22].

4. CARD9-Deficient Neutrophils and Autoimmune Diseases

In addition to its antimicrobial function, CARD9 has also been associated with human aseptic diseases including inflammatory bowel disease [23], rheumatoid arthritis [24], IgA nephropathy [25], and ankylosing spondylitis [26]. As reported previously [3, 4], CARD9 is not only present in dendritic cells and macrophages but also in neutrophils. Although CARD9 in dendritic cells and macrophages is confirmed to be involved in aseptic inflammation [27], its functions in neutrophils remain unclear.

CARD9 knockdown effectively alleviated autoantibody-induced arthritis and dermatitis in a mouse model [28]. CARD9-deficient neutrophils isolated from mice showed a normal respiratory burst and degranulation, but an obvious impairment in NF-κB activation, proinflammatory gene expression, and the release of various chemokines and cytokines. Furthermore, the CARD9-mediated signaling pathway in neutrophils was initiated via C-type lectin receptors in a receptor-proximal Src-family/Syk/PLCg2 module, leading to NF-κB activation and cytokine release through the CARD9/Bcl10/Maltl complex.

Because CARD9 is expressed in dendritic cells, macrophages, and neutrophils, it is difficult to dissect the inflammatory activity of CARD9-deficient neutrophils in patients and mice. To resolve this issue, mice specifically lacking CARD9 in the neutrophil compartment (referred to as CARD9^ΔPMN mice) were used to study autoantibody-induced arthritis and dermatitis, along with complete CARD9 knockout mice (referred to as CARD9^-/- mice). Compared with CARD9^-/- mice, CARD9^ΔPMN mice showed the same protection from in vivo inflammatory reactions, indicating that CARD9 in neutrophils, instead of macrophages and dendritic cells, was required for the autoantibody-induced inflammatory response. This was the first direct evidence that CARD9 deficiency in neutrophils plays an important role in suppressing in vivo inflammation [28].

CARD9 knockdown was also shown to ameliorate neutrophilic dermatosis in mice [29]. After in vitro incubation with recombinant murine IL-1α, CARD9 deficiency in neutrophils significantly dampened MAPK and NF-κB inflammatory signaling. Consequently, CARD9 in neutrophils may trigger an excessive inflammatory response in the mouse model of neutrophilic dermatosis.

5. Conclusions

CARD9 plays a critical role in innate immune defense. This review focuses on the effects of CARD9 deficiency on the host immune response in neutrophils. Of note, CARD9^ΔPMN mutant mice, with a lineage-specific deletion of CARD9 in their neutrophils, provide compelling evidence that CARD9 in neutrophils acts as a critical contributor to in vivo inflammation. However, the biological functions of CARD9 in neutrophils remain elusive. Further work will be required to determine whether the impaired killing capacity of CARD9-deficient neutrophils is a major contributor to fungal infection in these patients, how CARD9-deficient neutrophils operate their organ-specific functions against fungal infection in the CNS and skin, and why CARD9-deficient neutrophils exhibit a selective defect in fungal killing predisposing the host to C. albicans and P. verrucosa infection but not Aspergillus infection.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Authors’ Contributions

RS, ZY, ZM, and XU cowrote the manuscript.

Acknowledgments

Our profound admiration and respect goes out to the researchers in this field and in our laboratories for their dedication and hard work. The authors are grateful to the National Natural Science Foundation of China (81960452) and the Shanghai Natural Science Foundation (No. 19ZR1448400).

References

Z. W. Yang, C. Z. Weng, J. Wang, and P. Xu, “The role of Card9 overexpression in peripheral blood mononuclear cells from patients with aseptic acute pancreatitis,” Journal of Cellular and Molecular Medicine, vol. 20, no. 3, pp. 441–449, 2016.
View at: Publisher Site | Google Scholar
X. Zhong, B. Chen, L. Yang, and Z. Yang, “Molecular and physiological roles of the adaptor protein CARD9 in immunity,” Cell Death & Disease, vol. 9, no. 2, p. 52, 2018.
View at: Publisher Site | Google Scholar
A. Drewniak, R. P. Gazendam, A. T. Tool et al., “Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency,” Blood, vol. 121, no. 13, pp. 2385–2392, 2013.
View at: Publisher Site | Google Scholar
R. A. Drummond, A. L. Collar, M. Swamydas et al., “CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system,” Plos Pathogens, vol. 11, no. 12, article e1005293, 2015.
View at: Publisher Site | Google Scholar
M. Herbst, R. Gazendam, D. Reimnitz et al., “Chronic Candida albicans meningitis in a 4-year-old girl with a homozygous mutation in the CARD9 gene (Q295X),” Pediatric Infectious Disease Journal, vol. 34, no. 9, pp. 999–1002, 2015.
View at: Publisher Site | Google Scholar
J. T. Loh, S. Xu, J. X. Huo, S. S. Y. Kim, Y. Wang, and K. P. Lam, “Dok3-protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity,” Journal of Clinical Investigation, vol. 129, no. 7, pp. 2717–2729, 2019.
View at: Publisher Site | Google Scholar
P. G. Cetinkaya, D. C. Ayvaz, B. Karaatmaca et al., “A young girl with severe cerebral fungal infection due to card 9 deficiency,” Clinical Immunology, vol. 191, pp. 21–26, 2018.
View at: Publisher Site | Google Scholar
F. Lanternier, S. A. Mahdaviani, E. Barbati et al., “Inherited CARD9 deficiency in otherwise healthy children and adults with _Candida_ species -induced meningoencephalitis, colitis, or both,” Journal of Allergy and Clinical Immunology, vol. 135, no. 6, pp. 1558–1568.e2, 2015.
View at: Publisher Site | Google Scholar
S. Martin, E. Balligand, J. Peeters et al., “A 7-year-old child with headaches and prolonged fever associated with oral and nail lesions,” Open Forum Infectious Diseases, vol. 6, no. 11, article ofz229, 2019.
View at: Google Scholar
M. S. Lionakis, “New insights into innate immune control of systemic candidiasis,” Medical Mycology, vol. 52, no. 6, pp. 555–564, 2014.
View at: Publisher Site | Google Scholar
R. A. Drummond, M. Swamydas, V. Oikonomou et al., “CARD9⁺ microglia promote antifungal immunity via IL-1β\- and CXCL1-mediated neutrophil recruitment,” Nature Immunology, vol. 20, no. 5, pp. 559–570, 2019.
View at: Publisher Site | Google Scholar
J. Chang, M. R. Mancuso, C. Maier et al., “Gpr124 is essential for blood-brain barrier integrity in central nervous system disease,” Nature Medicine, vol. 23, no. 4, pp. 450–460, 2017.
View at: Publisher Site | Google Scholar
P. Liang, X. Wang, R. Wang, Z. Wan, W. Han, and R. Li, “CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa,” Mycopathologia, vol. 179, no. 5-6, pp. 347–357, 2015.
View at: Publisher Site | Google Scholar
X. Wang, W. Wang, Z. Lin et al., “CARD9 mutations linked to subcutaneous phaeohyphomycosis and T_H17 cell deficiencies,” Journal of Allergy and Clinical Immunology, vol. 133, no. 3, pp. 905–908.e3, 2014.
View at: Publisher Site | Google Scholar
M. De Bruyne, L. Hoste, D. J. Bogaert et al., “A CARD9 founder mutation disrupts NF-kappaB signaling by inhibiting BCL10 and MALT1 recruitment and signalosome formation,” Frontiers in Immunology, vol. 9, p. 2366, 2018.
View at: Google Scholar
L. Perez, F. Messina, R. Negroni et al., “Inherited CARD9 deficiency in a patient with both Exophiala spinifera and Aspergillus nomius severe infections,” Journal of Clinical Immunology, vol. 40, no. 2, pp. 359–366, 2020.
View at: Publisher Site | Google Scholar
N. Rieber, R. P. Gazendam, A. F. Freeman et al., “Extrapulmonary Aspergillus infection in patients with CARD9 deficiency,” JCI insight, vol. 1, no. 17, article e89890, 2016.
View at: Publisher Site | Google Scholar
E. P. Reeves, H. Lu, H. L. Jacobs et al., “Killing activity of neutrophils is mediated through activation of proteases by K⁺ flux,” Nature, vol. 416, no. 6878, pp. 291–297, 2002.
View at: Publisher Site | Google Scholar
R. P. Gazendam, J. L. van Hamme, A. T. Tool et al., “Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects,” Blood, vol. 124, no. 4, pp. 590–597, 2014.
View at: Publisher Site | Google Scholar
R. A. Drummond and M. S. Lionakis, “Mechanistic insights into the role of C-type lectin receptor/CARD9 signaling in human antifungal immunity,” Frontiers in Cellular and Infection Microbiology, vol. 6, p. 39, 2016.
View at: Google Scholar
D. Strasser, K. Neumann, H. Bergmann et al., “Syk kinase-coupled C-type lectin receptors engage protein kinase C-δ to elicit Card9 adaptor-mediated innate immunity,” Immunity, vol. 36, no. 1, pp. 32–42, 2012.
View at: Publisher Site | Google Scholar
A. Heinrich, K. A. Heyl, E. Klaile et al., “Moraxella catarrhalis induces CEACAM3-Syk-CARD9-dependent activation of human granulocytes,” Cellular Microbiology, vol. 18, no. 11, pp. 1570–1582, 2016.
View at: Publisher Site | Google Scholar
B. Lamas, M. Richard, V. Leducq et al., “CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands,” Nature Medicine, vol. 22, no. 6, pp. 598–605, 2016.
View at: Publisher Site | Google Scholar
R. Arya, I. del Rincon, V. S. Farook et al., “Genetic variants influencing joint damage in Mexican Americans and European Americans with rheumatoid arthritis,” Genetic Epidemiology, vol. 39, no. 8, pp. 678–688, 2015.
View at: Publisher Site | Google Scholar
K. Kiryluk, Y. Li, F. Scolari et al., “Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens,” Nature Genetics, vol. 46, no. 11, pp. 1187–1196, 2014.
View at: Publisher Site | Google Scholar
The Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2), Spondyloarthritis Research Consortium of Canada (SPARCC) et al., “Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility,” Nature Genetics, vol. 43, no. 8, pp. 761–767, 2011.
View at: Publisher Site | Google Scholar
X. Xu, J. F. Xu, G. Zheng et al., “CARD9^S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses,” Nature Immunology, vol. 19, no. 6, pp. 547–560, 2018.
View at: Publisher Site | Google Scholar
T. Nemeth, K. Futosi, C. Sitaru, J. Ruland, and A. Mocsai, “Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation _in vivo_,” Nature Communications, vol. 7, no. 1, p. 11004, 2016.
View at: Publisher Site | Google Scholar
S. Tartey, P. Gurung, P. Samir, A. Burton, and T. D. Kanneganti, “Cutting edge: dysregulated CARD9 signaling in neutrophils drives inflammation in a mouse model of neutrophilic dermatoses,” Journal of Neuroimmunology, vol. 201, no. 6, pp. 1639–1644, 2018.
View at: Google Scholar

Copyright

Copyright © 2021 Ruanmei Sheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1353

Downloads

853

Citations